Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3803875rdf:typepubmed:Citationlld:pubmed
pubmed-article:3803875lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:3803875lifeskim:mentionsumls-concept:C0442034lld:lifeskim
pubmed-article:3803875lifeskim:mentionsumls-concept:C0010819lld:lifeskim
pubmed-article:3803875lifeskim:mentionsumls-concept:C1301820lld:lifeskim
pubmed-article:3803875lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:3803875lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:3803875pubmed:issue11lld:pubmed
pubmed-article:3803875pubmed:dateCreated1987-3-17lld:pubmed
pubmed-article:3803875pubmed:abstractTextThe evaluation of 259 peritoneal cytologic specimens obtained intraoperatively in cases of malignant ovarian tumor revealed positive findings in 62.5%; findings were doubtful in 2.3% and unusable in 2.7%. In the cases with clinically apparent peritoneal carcinomatosis, (n = 175), cytologic tests were positive in 75%. Taking tumor histology into account the high proportion of positive findings among the non-classifiable tumors (11 out of 13) was striking. For this reason, in a second investigation, 144 peritoneal cytologic specimens taken exclusively from cases of serous carcinomas were studied with regard to their degree of differentiation, the time of removal, and tumor spread. The peritoneal cytology was positive in 33% of the cases without peritoneal carcinomatosis at the first operation and in 36% of the cases with only histologically detectable tumor remnants at the time of the second-look operation. With one exception, peritoneal cytology was also negative in 26 second-look cases without clinically or histologically detected tumors. The incidence of positive peritoneal cytology findings was significantly higher in serous tumors with low-grade differentiation.lld:pubmed
pubmed-article:3803875pubmed:languagegerlld:pubmed
pubmed-article:3803875pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3803875pubmed:citationSubsetIMlld:pubmed
pubmed-article:3803875pubmed:statusMEDLINElld:pubmed
pubmed-article:3803875pubmed:monthNovlld:pubmed
pubmed-article:3803875pubmed:issn0016-5751lld:pubmed
pubmed-article:3803875pubmed:authorpubmed-author:GöppingerAAlld:pubmed
pubmed-article:3803875pubmed:authorpubmed-author:HillemannsH...lld:pubmed
pubmed-article:3803875pubmed:authorpubmed-author:PfleidererAAlld:pubmed
pubmed-article:3803875pubmed:authorpubmed-author:HilgarthMMlld:pubmed
pubmed-article:3803875pubmed:issnTypePrintlld:pubmed
pubmed-article:3803875pubmed:volume46lld:pubmed
pubmed-article:3803875pubmed:ownerNLMlld:pubmed
pubmed-article:3803875pubmed:authorsCompleteYlld:pubmed
pubmed-article:3803875pubmed:pagination808-10lld:pubmed
pubmed-article:3803875pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:meshHeadingpubmed-meshheading:3803875-...lld:pubmed
pubmed-article:3803875pubmed:year1986lld:pubmed
pubmed-article:3803875pubmed:articleTitle[Significance of intraoperatively obtained peritoneal cytology in malignant ovarian tumors].lld:pubmed
pubmed-article:3803875pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3803875pubmed:publicationTypeEnglish Abstractlld:pubmed